ANDREW PALMER: Open Payments
NPI 1629555768 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,100 in 89 payments from 20 companies in 2025. Trend: 2023 $1,472 · 2024 $2,147 · 2025 $2,100
Food & beverage: $1,907Education: $193
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $402 |
| GlaxoSmithKline, LLC. | 11 | $283 |
| Regeneron Healthcare Solutions, Inc. | 14 | $231 |
| Viatris Specialty LLC | 11 | $172 |
| Grifols USA, LLC | 6 | $158 |
| JAZZ PHARMACEUTICALS INC. | 2 | $122 |
| SANOFI-AVENTIS U.S. LLC | 1 | $93 |
| Axsome Therapeutics, Inc. | 3 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $69 |
Products named: DUPIXENT, FASENRA, NUCALA, YUPELRI, Prolastin-C Liquid, XYWAV, TEZSPIRE, Sunosi.
Industry payments across MI — which companies pay providers there.
